Thar Pharma seeks $50M IPO to develop drug for chronic pain
Thar produces an oral version of an existing intravenous drug used to treat the estimated 80,000 Americans diagnosed annually with complex regional pain syndrome.
There are drugs to help fight painkiller addiction, but access is an issue with insurer restrictions
To Mark Publicker, a doctor in Portland, Maine, who practices addiction medicine, it’s a clear case of discrimination. You wouldn’t deprive a diabetic of insulin. You wouldn’t stop giving hypertension drugs to a patient with high blood pressure after successful treatment. You wouldn’t hold back a statin from a patient with high cholesterol. Yet Publicker’s […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Improving patient safety has to involve stopping errors with infusion pumps for post-op pain
Patient-controlled infusion pumps have been in use for 40 years, and while incremental improvements have been made, error rates remain unacceptably high -- these preventable mistakes must be avoided for future patients.
Clinical-stage Adynxx looks for success treating pain as a disease rather than a symptom
Despite the many avenues for treating pain these days, the Institute of Medicine estimates that it costs the U.S. a whopping $635 billion annually in medical charges and lost productivity. That’s the problem a young San Francisco pharmaceutical startup called Adynxx is trying to address. Existing drug treatments come with unpleasant or outright dangerous side […]